|
|
||||||||
RIIB1

*
Department of Life Science, Tokyo Institute of Technology, Yokohama, Japan;
Institute of Development, Aging and Cancer, Tohoku University, Sendai, Japan
Many studies have shown that Fc
RIIB is a negative regulator of B
cell receptor signaling, and even though Fc
RIIB is expressed through
all developmental stages of the B cell lineage, its involvement in
pre-B cell receptor (pre-BCR) signaling has not been examined. To
investigate Fc
RIIB function at the pre-B cell stage, we have
established pre-BCR positive pre-B cell lines from normal mice and
Fc
RIIB-deficient mice, named PreBR and Fc
-/-PreBR,
respectively. These cell lines are able to differentiate into immature
B cells in vitro by removal of IL-7. In PreBR, apoptosis was moderately
induced by F(ab')2 anti-µ Ab, but not by intact
anti-µ Ab. Phosphorylation of SH2-containing inositol
5-phosphatase (SHIP) and Dok, which are involved in Fc
RIIB
signaling, was induced by anti-µ cross-linking in PreBR. In
contrast, apoptosis was strongly induced by both the
F(ab')2 and intact anti-µ Abs in
Fc
-/-PreBR, and the level of phosphorylation of SHIP
or Dok was much lower in Fc
-/-PreBR than those
observed in PreBR. Restoration of Fc
RIIB to
Fc
-/-PreBR followed by anti-µ cross-linking
blocked severe apoptosis, and up-regulated SHIP and Dok
phosphorylation. The results demonstrate that Fc
RIIB negatively
regulates pre-BCR-mediated signaling for
apoptosis.
This article has been cited by other articles:
![]() |
C.-H. Ng, S. Xu, and K.-P. Lam Dok-3 plays a nonredundant role in negative regulation of B-cell activation Blood, July 1, 2007; 110(1): 259 - 266. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Niu, F. Roy, F. Saltel, C. Andrieu-Soler, W. Dong, A.-L. Chantegrel, R. Accardi, A. Thepot, N. Foiselle, M. Tommasino, et al. A nuclear export signal and phosphorylation regulate dok1 subcellular localization and functions. Mol. Cell. Biol., June 1, 2006; 26(11): 4288 - 4301. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Boulay, J.-G. Nemorin, and P. Duplay Phosphotyrosine Binding-Mediated Oligomerization of Downstream of Tyrosine Kinase (Dok)-1 and Dok-2 Is Involved in CD2-Induced Dok Phosphorylation J. Immunol., October 1, 2005; 175(7): 4483 - 4489. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Lee, C. Andrieu, F. Saltel, O. Destaing, J. Auclair, V. Pouchkine, J. Michelon, B. Salaun, R. Kobayashi, P. Jurdic, et al. I{kappa}B kinase {beta} phosphorylates Dok1 serines in response to TNF, IL-1, or {gamma} radiation PNAS, December 14, 2004; 101(50): 17416 - 17421. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Su, X. Li, J. C. Edberg, J. Wu, P. Ferguson, and R. P. Kimberly A Promoter Haplotype of the Immunoreceptor Tyrosine-Based Inhibitory Motif-Bearing Fc{gamma}RIIb Alters Receptor Expression and Associates with Autoimmunity. II. Differential Binding of GATA4 and Yin-Yang1 Transcription Factors and Correlated Receptor Expression and Function J. Immunol., June 1, 2004; 172(11): 7192 - 7199. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Shi, S. Ye, M. Bartlam, M. Yang, J. Wu, Y. Liu, F. Sun, X. Han, X. Peng, B. Qiang, et al. Structural Basis for the Specific Recognition of RET by the Dok1 Phosphotyrosine Binding Domain J. Biol. Chem., February 6, 2004; 279(6): 4962 - 4969. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Watanabe, M. Okano, H. Hattori, T. Yoshino, N. Ohno, N. Ohta, Y. Sugata, Y. Orita, T. Takai, and K. Nishizaki Roles of Fc{gamma}RIIB in Nasal Eosinophilia and IgE Production in Murine Allergic Rhinitis Am. J. Respir. Crit. Care Med., January 1, 2004; 169(1): 105 - 112. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. C. Otero and R. C. Rickert CD19 Function in Early and Late B Cell Development. II. CD19 Facilitates the Pro-B/Pre-B Transition J. Immunol., December 1, 2003; 171(11): 5921 - 5930. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Nutku, H. Aizawa, S. A. Hudson, and B. S. Bochner Ligation of Siglec-8: a selective mechanism for induction of human eosinophil apoptosis Blood, June 15, 2003; 101(12): 5014 - 5020. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |